Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers

被引：0
|
作者：
Henk van der Poel
Laurence Klotz
Gerald Andriole
Abdel-Rahmène Azzouzi
Anders Bjartell
Olivier Cussenot
Freddy Hamdy
Markus Graefen
Paolo Palma
Arturo Rodriguez Rivera
Christian G. Stief
机构：
[1] Netherlands Cancer Institute,Department of Urology
[2] University of Toronto,Division of Urology, Sunnybrook Health Science Centre
[3] Washington University St Louis,Division of Urology, Department of Surgery
[4] CHU d’Angers,Service d’Urologie
[5] Sahlgrenska Academy at the University of Gothenburg,Department of Urology, Institute of Clinical Sciences
[6] UPMC Univ Paris 06,Institute Universitaire de Cancerologie
[7] GRC-05,Nuffield Department of Surgical Sciences
[8] ONCOTYPE-Uro,Martini
[9] University of Oxford,Clinic Prostate Cancer Center
[10] University Medical Center Hamburg-Eppendorf,Department of Urology
[11] Universidade Estadual de Campinas,Department of Urology, Klinikum Großhadern, University Hospital Munich
[12] Hospital General Tlahuac,Großhadern
[13] Ludwig-Maximillians-University München,undefined
来源：
World Journal of Urology | 2015年 / 33卷
关键词：
Prostate cancer; Focal therapy; Active surveillance; Low risk; Intermediate risk; Consensus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：907 / 916
页数：9
相关论文
共 50 条
  • [1] Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers
    van der Poel, Henk
    Klotz, Laurence
    Andriole, Gerald
    Azzouzi, Abdel-Rahmene
    Bjartell, Anders
    Cussenot, Olivier
    Hamdy, Freddy
    Graefen, Markus
    Palma, Paolo
    Rodriguez Rivera, Arturo
    Stief, Christian G.
    [J]. WORLD JOURNAL OF UROLOGY, 2015, 33 (07) : 907 - 916
  • [2] Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance
    Courtney, P. Travis
    Deka, Rishi
    Kotha, Nikhil, V
    Cherry, Daniel R.
    Salans, Mia A.
    Nelson, Tyler J.
    Kumar, Abhishek
    Luterstein, Elaine
    Yip, Anthony T.
    Nalawade, Vinit
    Parsons, J. Kellogg
    Kader, A. Karim
    Stewart, Tyler F.
    Rose, Brent S.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (02): : 151 - +
  • [3] Patterns of multispecialty care for low- and intermediate-risk prostate cancer in the use of active surveillance
    Zambrano, Ibardo A.
    Hwang, Soohyun
    Basak, Ram
    Spratte, Brooke Namboodri
    Filson, Christopher P.
    Jacobs, Bruce L.
    Tan, Hung-Jui
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (09) : 388.e1 - 388.e8
  • [4] FOCAL CRYOTHERAPY FOR LOW- TO INTERMEDIATE-RISK PROSTATE CANCER: LONG TERM RESULTS AND MATCHED PAIR COMPARISON WITH ACTIVE SURVEILLANCE
    Marra, Giancarlo
    Soeterik, Timo
    Oreggia, Davide
    Pasquali, Caio
    Tourinho-Barbosa, Rafael
    Moschini, Marco
    Filippini, Claudia
    van Melick, Harm H. E.
    van den Bergh, Roderick C. N.
    Gontero, Paolo
    Cathala, Nathalie
    Macek, Petr
    Sanchez-Salas, Rafael
    Cathelineau, Xavier
    [J]. JOURNAL OF UROLOGY, 2021, 206 : E817 - E817
  • [5] Oncologic outcomes of radiation therapy following active surveillance for low- and intermediate-risk localized prostate cancer.
    Ahmad, Ardalan
    Chua, Melvin
    Murgic, Jure
    Raziee, Hamid Reza
    Hosni, Ali
    De Moraes, Fabio Ynoe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [6] Active surveillance and focal therapy for low-intermediate risk prostate cancer
    Klotz, Laurence
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2015, 4 (03) : 342 - 354
  • [7] A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer
    Kato, Takuma
    Tohi, Yoichiro
    Honda, Tomoko
    Matsuda, Iori
    Osaki, Yu
    Naito, Hirohito
    Matsuoka, Yuki
    Okazoe, Homare
    Taoka, Rikiya
    Tsunemori, Hiroyuki
    Ueda, Nobufumi
    Sugimoto, Mikio
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (03) : 289 - 297
  • [8] No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance
    Cyll, Karolina
    Loffeler, Sven
    Carlsen, Birgitte
    Skogstad, Karin
    Plathan, May Lisbeth
    Landquist, Martin
    Haug, Erik Skaaheim
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [9] No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance
    Karolina Cyll
    Sven Löffeler
    Birgitte Carlsen
    Karin Skogstad
    May Lisbeth Plathan
    Martin Landquist
    Erik Skaaheim Haug
    [J]. Scientific Reports, 12
  • [10] Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
    Kunogi, Hiroaki
    Wakumoto, Yoshiaki
    Kawamoto, Terufumi
    Oshima, Masaki
    Horie, Shigeo
    Sasai, Keisuke
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2020, 12 (06) : 554 - 561
12345